DDI-DrugBank.d722.s0 >> There is usually complete cross-resistance between PURINETHOL (mercaptopurine) and TABLOID brand Thioguanine. >> 51-60,63-76,83-89,97-107
DDI-DrugBank.d722.s1 >> As there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, mesalazine, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy. >> 35-61,70-79,82-91,97-110,212-222
